Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Curr Probl Cancer. 2013 May-Jun;37(3):110–144. doi: 10.1016/j.currproblcancer.2013.06.001

Table 6.

KI interactions with drugs and food are listed. In general, when antacids are used, avoid concurrent intake with KIs to maximize KI absorption.

Kinase Inhibitor Food Effect CYP 3A4 inducer CYP 3A4 Inhibitor Effect on Concurrent Medications Proton Pump Inhibitor Statin Warfarin
Axitinib No Decrease KI level; avoid inducer Increase KI level; Reduce KI dose Does not inhibit CYP3A4 No adjustment
Bosutinib With food Decrease KI level; avoid inducer Increase KI level; Avoid inhibitor Decrease KI level; use antacid, H2 2 hr later
Cabozantinib Empty Stomach Decrease KI level; avoid inducer Increase KI level; Avoid inhibitor CYP3A4 substrate increase
Crizotinib No Decrease KI level; avoid inducer Increase KI level; Avoid inhibitor CYP3A4 substrate increase
Dasatinib No Decrease KI level; increase KI dose Increase KI level; Reduce KI dose CYP3A4 substrate increase Do not use PPI, H2; use antacid 2 hr later Simvastatin's AUC increase
Erlotinib Empty stomach Decrease KI level; increase KI dose Increase KI level; Reduce KI dose CYP3A4 substrate increase Do not use PPI; take erlotinib 10 hr later or 2 hr before H2; use antacid 2 hr later High INR
Gefitinib No Decrease KI level; increase dose to 500 mg Increase KI level; Avoid inhibitor H2 reduced AUC
Imatinib With food Decrease KI level; increase KI dose Increase KI level; Avoid inhibitor CYP3A4 substrate increase Simvastatin's AUC increase
Lapatinib Empty stomach Decrease KI level; increase KI dose Increase KI level; Reduce KI dose CYP3A4 substrate increase Esomeprazole did not reduce KI level
Nilotinib Empty stomach Decrease KI level; avoid inducer Increase KI level; Reduce KI dose CYP3A4 substrate increase Decrease KI level;use antacid, H2, 2 hr later; gastrectomy decrease KI level No change
Pazopanib Empty Stomach Decrease KI level; avoid inducer Increase KI level; Reduce KI dose CYP3A4 substrate change No change
Regorafenib With food Decrease KI level; avoid inducer Increase KI level; Avoid inhibitor CYP3A4 substrate increase
Ruxolitinib No No adjustment Increase KI level; Reduce KI dose
Sorafenib Empty stoma ch Decrease KI level; avoid inducer Ketoconazole, no effect Not inhibit CYP3A4
Sunitinib No Decrease KI level; increase KI dose Increase KI level; Reduce KI dose No effect on major CYP
Vandetanib No Decrease KI level; avoid inducer Itraconazole, no effect Avoid; QT prolonging/ar rhythmic
Vemurafenib No Decrease KI level; avoid inducer Increase KI level; Avoid inhibitor CYP3A4 substrate change Warfarin AUC 18% increase
Vismodegib No No effect No effect PPI, H2, and antacid may decrease KI level
Ponatinib No avoid inducer Increase KI level; Reduce to 30mg No effect on major CYP Not evaluated; antiacid may reduce KI level

Abbreviations: AUC, area under the curve; H2, Histamine H2 receptor blocker; HR, hour; KI, kinase inhibitor